Neumora Therapeutics Stock (NASDAQ: NMRA) stock price, news, charts, stock research, profile.
Open | $9.840 |
Close | $9.780 |
Volume / Avg. | 376.381K / 661.963K |
Day Range | 9.550 - 10.180 |
52 Wk Range | 8.820 - 21.000 |
Market Cap | $1.594B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 7.89% |
Days to Cover | 14.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Neumora Therapeutics (NASDAQ:NMRA) through any online brokerage.
Other companies in Neumora Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
There is no analysis for Neumora Therapeutics
Neumora Therapeutics has a consensus price target of $19.83.
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $9.99 last updated June 14, 2024 at 4:33 PM EDT.
There are no upcoming dividends for Neumora Therapeutics.
Neumora Therapeutics’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Neumora Therapeutics.
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.